Perspective Therapeutics Inc.
CATX
$2.52-5.45%
End of day · as of Oct 13, 2026, 8:00 AM ET
Mkt cap
$280.58M
EV/Sales
N/A
P/E ratio
N/A
FY2022 Revenue
N/A
EPS (H1 2026)
$-0.47
Gross Margin (FY2022)
N/A
Profit Margin (FY2022)
N/A
Beta
1.12
Div yield
N/A
Sector
Healthcare
Perspective Therapeutics Inc. (CATX) is a medical devices company listed on US.
Latest reported CATX revenue for 2022-12-31 was $0. Net income was -$10.8M. CATX currently screens at market cap $280.6M.
Use this CATX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CATX income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Perspective Therapeutics Inc. (CATX) is a medical devices company in the Healthcare sector.
Latest cached Perspective Therapeutics Inc. (CATX) net income for Dec 31, 2022 was -$10.8M. Statements: https://lician.com/financials/catx
Perspective Therapeutics Inc. (CATX) market capitalization is $280.6M on the latest cached snapshot.
Perspective Therapeutics Inc. (CATX) cached previous close $2.66; day range $2.51 – $2.61; volume 640,025. Session quote: https://lician.com/quote/catx
Perspective Therapeutics Inc. (CATX) latest cached earnings event is "CATX earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CATX filing is 8-K · Oct 23, 2026. Filings: https://lician.com/sec/catx